Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine in Pulmonary Hypertension with RV Dysfunction
NCT01839110Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2013
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ranolazine in pulmonary hypertension (PH), sponsored by University of Pennsylvania. Started Jul 2013; status: completed.
02
Drugs
ranolazine
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01839110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01839110.